Showing results (111-120 of 145) with videos related to
Sort By:
Pageof 15
Tropical Medicine & International Health : TM & IH|April 27, 2018
Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio-behavioural surveillance survey in 2015Ghobad Moradi, Mohammad-Mehdi Gouya, Fatemeh Azimizan Zavareh, et al.Bulletin of the World Health Organization|January 24, 2007
Association of physical activity and dietary behaviours in relation to the body mass index in a national sample of Iranian children and adolescents: CASPIAN StudyRoya Kelishadi, Gelayol Ardalan, Riaz Gheiratmand, et al.European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|December 5, 2006
Blood pressure and its influencing factors in a national representative sample of Iranian children and adolescents: the CASPIAN StudyRoya Kelishadi, Gelayol Ardalan, Riaz Gheiratmand, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 16, 2007
Factors associated with the metabolic syndrome in a national sample of youths: CASPIAN StudyRoya Kelishadi, Mohammad Mehdi Gouya, Khosrow Adeli, et al.Plos One|June 5, 2014
Vulnerability of homeless people in Tehran, Iran, to HIV, tuberculosis and viral hepatitisFahimeh Bagheri Amiri, Mohammad Mehdi Gouya, Mahnaz Saifi, et al.Inquiry : a Journal of Medical Care Organization, Provision and Financing|May 29, 2023
The Psychometric Properties of Intention to Receive the COVID-19 Vaccine Scale Based on the Health Belief ModelKhadijeh Hajimiri, Alireza Shoghli, Zarrintaj Hoseinzade, et al.Harm Reduction Journal|August 16, 2023
Double counting of clients using services in Iran: implications for assessing the reach of harm reduction programsFatemeh Tavakoli, Willi Mcfarland, Nima Ghalekhani, et al.Iranian Journal of Parasitology|October 27, 2023
Visceral Leishmaniasis in Iran: An Update on Epidemiological Features from 2013 to 2022Mehdi Mohebali, Gholamhossein Edrissian, Behnaz Akhoundi, et al.BMC Public Health|July 24, 2023
A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in IranShahin Soltani, Behzad Karami Matin, Mohammad Mehdi Gouya, et al.Harm Reduction Journal|October 21, 2020
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals eraSanam Hariri, Heidar Sharafi, Mahdi Sheikh, et al.Pageof 15